Vanda Pharmaceuticals Ownership | Who Owns Vanda Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Vanda Pharmaceuticals Ownership Summary


Vanda Pharmaceuticals is owned by 75.29% institutional investors, 3.16% insiders, and 21.55% retail investors. Blackrock is the largest institutional shareholder, holding 14.09% of VNDA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.99% of its assets in Vanda Pharmaceuticals shares.

VNDA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockVanda Pharmaceuticals75.29%3.16%21.55%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock8.14M14.09%$45.98M
Renaissance4.11M7.12%$23.24M
Vanguard group3.43M5.94%$19.39M
Tang capital management2.15M3.73%$12.17M
Dimensional fund advisors lp2.01M3.49%$11.38M
Acadian asset management1.98M3.43%$11.19M
Nantahala capital management1.59M2.76%$9.00M
Jacobs levy equity management1.49M2.57%$8.40M
Geode capital management1.33M2.30%$7.52M
State street1.21M2.10%$6.84M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Profit investment management571.32K2.02%$3.23M
Krensavage asset management662.17K1.72%$3.74M
Bml capital management398.28K1.61%$2.25M
Tang capital management2.15M1.24%$12.17M
Nantahala capital management1.59M0.53%$9.00M
Monaco asset management sam192.93K0.17%$1.09M
Virtus investment advisers28.25K0.14%$159.64K
Diametric capital, lp25.00K0.08%$141.25K
Clearalpha technologies lp40.00K0.07%$226.00K
Bridgeway capital management437.96K0.06%$2.47M

Top Buyers

HolderShares% AssetsChange
Schroder investment management group1.16M0.01%1.16M
Krensavage asset management662.17K1.72%662.17K
Nantahala capital management1.59M0.53%580.26K
Tang capital management2.15M1.24%401.65K
Bml capital management398.28K1.61%398.28K

Top Sellers

HolderShares% AssetsChange
Bank of america corp /de/77.42K--1.13M
D. e. shaw692.74K0.00%-1.11M
Morgan stanley497.22K0.00%-1.01M
Assenagon asset management---730.82K
Two sigma advisers, lp214.10K0.00%-489.80K

New Positions

HolderShares% AssetsChangeValue
Schroder investment management group1.16M0.01%1.16M$6.53M
Krensavage asset management662.17K1.72%662.17K$3.74M
Bml capital management398.28K1.61%398.28K$2.25M
Kennedy capital management229.06K0.03%229.06K$1.29M
Commonwealth of pennsylvania public school empls retrmt sys175.00K0.01%175.00K$988.75K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-10.00
Assetmark-31.00
Lindbrook capital-73.00
First manhattan co. llc.-100.00
Innealta capital-134.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20241581.94%43,866,8090.75%751.32%73-14.12%5110.87%
Jun 30, 20241534.79%43,538,769-9.37%751.09%8329.69%46-20.69%
Mar 31, 2024146-8.18%48,037,922-4.96%831.08%64-20.99%585.45%
Dec 31, 2023159-13.11%50,545,253-3.66%871.06%81-10.99%55-17.91%
Sep 30, 2023183-3.68%52,465,300-6.73%910.95%91-7.14%679.84%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.74M2.99%-
iShares Russell 2000 ETF1.58M2.70%-3.29K
International Biotechnology Ord1.04M1.78%194.02K
Vanguard Institutional Extnd Mkt Idx Tr898.43K1.54%-
BlackRock Advantage Small Cap Core Instl833.46K1.43%-
Federated Hermes MDT Small Cap Core IS624.55K1.07%-
Federated Hermes MDT SCC Institutional624.55K1.07%-
Fidelity Small Cap Index572.13K0.98%-6.99K
iShares Russell 2000 Value ETF547.88K0.94%708.00
Nuveen Quant Small Cap Equity R6530.50K0.91%166.10K

Recent Insider Transactions


DateNameRoleActivityValue
Nov 14, 2024Mitchell Stephen Ray-Sell$25.86K
Jul 29, 2024Moran Kevin Patrick SVP, CFO & TreasurerSell$13.33K
Mar 05, 2024Williams Timothy SVP & General CounselSell$37.40K
Mar 04, 2024Williams Timothy SVP & General CounselSell$35.92K
Mar 05, 2024Wijkstrom Joakim SVP, Chief Marketing OfficerSell$38.83K

Insider Transactions Trends


DateBuySell
2024 Q3-1
2024 Q2--
2024 Q1-10
2023 Q3-4
2023 Q2-2

VNDA Ownership FAQ


Who Owns Vanda Pharmaceuticals?

Vanda Pharmaceuticals shareholders are primarily institutional investors at 75.29%, followed by 3.16% insiders and 21.55% retail investors. The average institutional ownership in Vanda Pharmaceuticals's industry, Biotech Stocks , is 47.04%, which Vanda Pharmaceuticals exceeds.

Who owns the most shares of Vanda Pharmaceuticals?

Vanda Pharmaceuticals’s largest shareholders are Blackrock (8.14M shares, 14.09%), Renaissance (4.11M shares, 7.12%), and Vanguard group (3.43M shares, 5.94%). Together, they hold 27.15% of Vanda Pharmaceuticals’s total shares outstanding.

Does Blackrock own Vanda Pharmaceuticals?

Yes, BlackRock owns 14.09% of Vanda Pharmaceuticals, totaling 8.14M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 45.98M$. In the last quarter, BlackRock decreased its holdings by -1.629K shares, a -0.02% change.

Who is Vanda Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Profit investment management is Vanda Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 2.02% of its assets in 571.32K Vanda Pharmaceuticals shares, valued at 3.23M$.

Who is the top mutual fund holder of Vanda Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Vanda Pharmaceuticals shares, with 2.99% of its total shares outstanding invested in 1.74M Vanda Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools